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Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) posses great potential for applications in regenerative medicine, disease modeling, and developmental biology studies. This potential relies on the ability of these cells to differentiate into the hundreds of cell types within the body. Here, we highlight some of strategies for directing the differentiation of ESCs and iPSCs into defined cell types. Most cell types and pathways depicted correspond to published work on human cells, except for the production of spermatozoa, oocyte-like cells, otic hair cells, cortical layers, and optic cup, which were generated with mouse ESCs or iPSCs. In order to uncover these differentiation strategies, stem cell biologists have relied heavily on previous research in model organisms, including Drosophila, Xenopus, chick, and mouse. Early in embryonic development, one of the first cellular differentiation events occurs during gastrulation, which results in the formation of the three germ layers: ectoderm, mesoderm, and endoderm. Similarly, many of the directed differentiation methods rely on the initial specification of ESCs or iPSCs into one of these multipotent lineages, followed by the generation of the particular cell type of interest. The relevant signaling pathways to manipulate in vitro can be gleaned from developmental studies; however, directing the differentiation to defined cell types requires considerable optimization of the precise concentrations, timing, and combinations of factors and small molecules.
For this SnapShot, we have indicated key growth and differentiation factors for each pathway in blue and small molecules in red; specific culturing conditions such as coculture with stromal cells are also indicated. Successful differentiation toward a particular cell type is typically determined by the expression of specific markers identified through in vivo studies, but in many cases, additional phenotypic analyses of cells derived from pluripotent stem cells are performed. Although the field of directed differentiation has made rapid progress, many issues remain, including the validation of the maturity and functionality of many of the human cell types derived in vitro (e.g., pancreatic β cells, hepatocytes) and the generation of more complex structures with tissue-or organ-like organization and function. Nevertheless, these challenges represent exciting opportunities for future studies and discoveries.
Abbreviations β-GP, β-glycerol phosphate; BMP, bone morphogenetic protein; CNTF, ciliary neurotrophic factor; CSF, colony-stimulating factor; Dexa, dexamethasone; DKK, Dickkopf; EGF, epidermal growth factor; EPO, erythropoietin; FGF, fibroblast growth factor; FLT, FMS-like tyrosine kinase ligand; FP6, IL-6 + IL-6 soluble receptor; GDF, growth differentiation factor; hCG, human chorionic gonadotropin; HGF, hepatocyte growth factor; IBXT, isobutylxanthine; IGF, insulin-like growth factor; IL, interleukin; KSR, knockout serum replacement; Lif, leukemia inhibitory factor; M-CSF, macrophage colony-stimulating factor; NT4, neurotrophin; PDGF, platelet-derived growth factor; RA, retinoic acid; RANKL, receptor activator of nuclear factor kappa β ligand; SCF, stem cell factor; SFEBq, Serum-free of embryoid body-like aggregates; SHH, Sonic hedgehog; TGF-β, transforming growth factor β; TPO, thrombopoietin; VEGF, vascular endothelial growth factor.
